EUVIMEDEUVIMED entdecken
Crossref

Short-chain fatty acids promote post-myocardial infarction cardiac repair via FFAR2-dependent suppression of osteoclast-like macrophage differentiation

Qun Zhang, Xue Jiang, Lu Liu, Yu-Meng Jia, Pan-Pan Yu, Jie Zhang, Xin-Ying Guo, Jing-Jing Wang, Cai-Xia Guo, Lei Wang

Basic Research in Cardiology · 2026

DOI: 10.1007/s00395-026-01212-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, 2026. Verfasst von Qun Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaomin Lane, Dongcheng District, Beijing, 100730, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Macrophages, Cell Differentiation, Osteoclasts. Die Arbeit nennt 103 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adverse cardiac remodeling leads to the development of heart failure following myocardial infarction (MI), yet the immunometabolic signals governing early infarct repair remain poorly understood. Short-chain fatty acids (SCFAs) are important immunometabolic regulators, but their relevance and mechanistic contribution to post-MI repair remain unclear. Here, we integrated clinical observations with genetic and pharmacological intervention studies to investigate the role of the SCFAs-free fatty acid receptor 2 (FFAR2) axis in post-MI repair. Circulating SCFAs levels were markedly decreased in patients with MI, and associated with more complex coronary lesions and a higher risk of major adverse cardiovascular events. In murine MI, SCFAs supplementation reduced infarct expansion, cardiomyocyte death, and cardiac rupture, and improved left-ventricular function. These benefits were lost in global and myeloid-specific Ffar2-deficient mice, demonstrating an essential role for myeloid FFAR2 in SCFA-mediated cardioprotection. Mechanistically, SCFAs activated FFAR2-Gαi signaling in macrophages to suppress RANKL-RANK-driven osteoclast-like macrophage differentiation. thereby enhancing early fibrotic stabilization, reducing cardiomyocyte apoptosis, and improving infarct healing. Pharmacological blockade of osteoclast-like macrophage activation partially rescued impaired healing and cardiac dysfunction in myeloid-specific Ffar2-deficient mice after MI. These findings identify circulating SCFAs as clinically relevant biomarkers associated with coronary lesion complexity and adverse clinical outcomes after MI, and establish the SCFAs-FFAR2 axis as an immune-metabolic pathway that orchestrates macrophage fate and infarct healing. Targeting SCFAs-FFAR2 signaling may represent a therapeutic strategy to limit adverse post-MI remodeling and prevent heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMacrophagesCell DifferentiationOsteoclastsReceptors, G-Protein-CoupledFatty Acids, VolatileVentricular RemodelingAnimalsHumansMaleMice, Inbred C57BLMice, KnockoutDisease Models, AnimalSignal TransductionApoptosisMiceMyocytes, Cardiac

Stichwörter der Autor:innen

Adverse cardiac remodelingFree fatty acid receptor 2Myocardial infarctionOsteoclast-like macrophageShort-chain fatty acids

Substanzen

Receptors, G-Protein-CoupledFfar2 protein, mouseFatty Acids, Volatile

Autor:innen und Institutionen

  • Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaomin Lane, Dongcheng District, Beijing, 100730, China.
  • Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beijing, 100069, China.
  • Department of Laboratory Animals, Capital Medical University, Beijing, 100069, China.
  • Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beijing, 100069, China. lei.wang2@ccmu.edu.cn.
  • The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing, 100029, China. lei.wang2@ccmu.edu.cn.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Capital's Funds for Health Improvement and Research
  • Beijing Natural Science Foundation
  • Beijing High-Level Public Health Technical Talent Program-Leading Talent
  • priming scientific research foundation for the junior researcher in Beijing Tongren Hospital, Capital Medical University
  • The initial funding for introducing talents to Capital Medical University
  • Capital’s Funds for Health Improvement and Research

Zitieren

APA

Zhang, Q., Jiang, X., Liu, L., Jia, Y. M., Yu, P. P., Zhang, J., Guo, X. Y., Wang, J. J., Guo, C. X., & Wang, L. (2026). Short-chain fatty acids promote post-myocardial infarction cardiac repair via FFAR2-dependent suppression of osteoclast-like macrophage differentiation. Basic Research in Cardiology. https://doi.org/10.1007/s00395-026-01212-6

Vancouver

Zhang Q, Jiang X, Liu L, Jia YM, Yu PP, Zhang J, et al. Short-chain fatty acids promote post-myocardial infarction cardiac repair via FFAR2-dependent suppression of osteoclast-like macrophage differentiation. Basic Research in Cardiology. 2026. doi:10.1007/s00395-026-01212-6

BibTeX
@article{Zhang2026,
  author = {Zhang, Qun and Jiang, Xue and Liu, Lu and Jia, Yu-Meng and Yu, Pan-Pan and Zhang, Jie and Guo, Xin-Ying and Wang, Jing-Jing and Guo, Cai-Xia and Wang, Lei},
  title = {Short-chain fatty acids promote post-myocardial infarction cardiac repair via FFAR2-dependent suppression of osteoclast-like macrophage differentiation},
  journal = {Basic Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00395-026-01212-6}
}
Kostenlos starten →